This week, the FDA fast tracks a home-based OCT system, late-night screen time resets the circadian clock and a new retinal implant is (literally) out of this world. Source: AAO
The current study describes the outcomes of globe-preserving surgery combined with high-dose proton beam radiation (PBR) in treating patients with primary adenoid cystic carcinoma of the lacrimal gland. Source: AAO
Ocular Therapeutix announced FDA clearance of their dexamethasone punctum plug (Dextenza) for managing ocular pain after cataract surgery. The implant is the first intracanalicular drug delivery device. Source: AAO
This prospective study evaluated whether ultrasonographic optic nerve sheath diameter (ONSD) measurements could be used to monitor intracranial pressure (ICP). Source: AAO
Investigators examined the efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant Graves orbitopathy (GO). Source: AAO
This study assessed the safety and feasibility of delivering retinal pigment epithelial (RPE) cells derived from a human embryo into the subretinal space of patients with macular degeneration. Source: AAO
This week, cataract formation seems a lot like playing hot potato, an undercover nanoparticle offers a less toxic alternative to mitomycin-C and a light scalpel makes nanoscale incisions on the retinal cell surface. Source: AAO
This retrospective study evaluated the effectiveness of corneal cross-linking (CXL) in eyes with advanced keratoconus. Source: AAO
Investigators prospectively compared the effects of bromfenac and indomethacin on intraoperative pupil size during cataract surgery. Source: AAO
This longitudinal, observational study assessed the association between physical activity and rate of visual field loss in patients with glaucoma. Source: AAO